Global Microbiome Therapies Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 45762
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Microbiome Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microbiome Therapies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Microbiome Therapies market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Microbiome Therapies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Bacteria

Fungi

Virus

Others

Market segment by Application, can be divided into

Testing Centres

Research Labs

Horticulture

Others

Market segment by players, this report covers

uBiome

Evolve BioSystems

Indigo Agriculture

Pivot Bio

Concentric Ag

Epibiome

CosmosID

Human Longevity

Ajinomoto Cambrooke

AnimalBiome

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Microbiome Therapies

1.2 Classification of Microbiome Therapies by Microbes

1.2.1 Overview: Global Microbiome Therapies Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Microbiome Therapies Revenue Market Share by Type in 2020

1.2.3 Bacteria

1.2.4 Fungi

1.2.5 Virus

1.2.6 Others

1.3 Global Microbiome Therapies Market by End User

1.3.1 Overview: Global Microbiome Therapies Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Testing Centres

1.3.3 Research Labs

1.3.4 Horticulture

1.3.5 Others

1.4 Global Microbiome Therapies Market Size & Forecast

1.5 Global Microbiome Therapies Market Size and Forecast by Region

1.5.1 Global Microbiome Therapies Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Microbiome Therapies Market Size by Region, (2016-2021)

1.5.3 North America Microbiome Therapies Market Size and Prospect (2016-2026)

1.5.4 Europe Microbiome Therapies Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Microbiome Therapies Market Size and Prospect (2016-2026)

1.5.6 South America Microbiome Therapies Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Microbiome Therapies Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Microbiome Therapies Market Drivers

1.6.2 Microbiome Therapies Market Restraints

1.6.3 Microbiome Therapies Trends Analysis

2 Company Profiles

2.1 uBiome

2.1.1 uBiome Details

2.1.2 uBiome Major Business

2.1.3 uBiome Microbiome Therapies Product and Solutions

2.1.4 uBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 uBiome Recent Developments and Future Plans

2.2 Evolve BioSystems

2.2.1 Evolve BioSystems Details

2.2.2 Evolve BioSystems Major Business

2.2.3 Evolve BioSystems Microbiome Therapies Product and Solutions

2.2.4 Evolve BioSystems Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Evolve BioSystems Recent Developments and Future Plans

2.3 Indigo Agriculture

2.3.1 Indigo Agriculture Details

2.3.2 Indigo Agriculture Major Business

2.3.3 Indigo Agriculture Microbiome Therapies Product and Solutions

2.3.4 Indigo Agriculture Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Indigo Agriculture Recent Developments and Future Plans

2.4 Pivot Bio

2.4.1 Pivot Bio Details

2.4.2 Pivot Bio Major Business

2.4.3 Pivot Bio Microbiome Therapies Product and Solutions

2.4.4 Pivot Bio Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Pivot Bio Recent Developments and Future Plans

2.5 Concentric Ag

2.5.1 Concentric Ag Details

2.5.2 Concentric Ag Major Business

2.5.3 Concentric Ag Microbiome Therapies Product and Solutions

2.5.4 Concentric Ag Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Concentric Ag Recent Developments and Future Plans

2.6 Epibiome

2.6.1 Epibiome Details

2.6.2 Epibiome Major Business

2.6.3 Epibiome Microbiome Therapies Product and Solutions

2.6.4 Epibiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Epibiome Recent Developments and Future Plans

2.7 CosmosID

2.7.1 CosmosID Details

2.7.2 CosmosID Major Business

2.7.3 CosmosID Microbiome Therapies Product and Solutions

2.7.4 CosmosID Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 CosmosID Recent Developments and Future Plans

2.8 Human Longevity

2.8.1 Human Longevity Details

2.8.2 Human Longevity Major Business

2.8.3 Human Longevity Microbiome Therapies Product and Solutions

2.8.4 Human Longevity Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Human Longevity Recent Developments and Future Plans

2.9 Ajinomoto Cambrooke

2.9.1 Ajinomoto Cambrooke Details

2.9.2 Ajinomoto Cambrooke Major Business

2.9.3 Ajinomoto Cambrooke Microbiome Therapies Product and Solutions

2.9.4 Ajinomoto Cambrooke Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Ajinomoto Cambrooke Recent Developments and Future Plans

2.10 AnimalBiome

2.10.1 AnimalBiome Details

2.10.2 AnimalBiome Major Business

2.10.3 AnimalBiome Microbiome Therapies Product and Solutions

2.10.4 AnimalBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 AnimalBiome Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Microbiome Therapies Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Microbiome Therapies Players Market Share

3.2.2 Top 10 Microbiome Therapies Players Market Share

3.2.3 Market Competition Trend

3.3 Microbiome Therapies Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Microbiome Therapies Revenue and Market Share by Type (2016-2021)

4.2 Global Microbiome Therapies Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Microbiome Therapies Revenue Market Share by Application (2016-2021)

5.2 Microbiome Therapies Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Microbiome Therapies Revenue by Type (2016-2026)

6.2 North America Microbiome Therapies Revenue by Application (2016-2026)

6.3 North America Microbiome Therapies Market Size by Country

6.3.1 North America Microbiome Therapies Revenue by Country (2016-2026)

6.3.2 United States Microbiome Therapies Market Size and Forecast (2016-2026)

6.3.3 Canada Microbiome Therapies Market Size and Forecast (2016-2026)

6.3.4 Mexico Microbiome Therapies Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Microbiome Therapies Revenue by Type (2016-2026)

7.2 Europe Microbiome Therapies Revenue by Application (2016-2026)

7.3 Europe Microbiome Therapies Market Size by Country

7.3.1 Europe Microbiome Therapies Revenue by Country (2016-2026)

7.3.2 Germany Microbiome Therapies Market Size and Forecast (2016-2026)

7.3.3 France Microbiome Therapies Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Microbiome Therapies Market Size and Forecast (2016-2026)

7.3.5 Russia Microbiome Therapies Market Size and Forecast (2016-2026)

7.3.6 Italy Microbiome Therapies Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Microbiome Therapies Revenue by Type (2016-2026)

8.2 Asia-Pacific Microbiome Therapies Revenue by Application (2016-2026)

8.3 Asia-Pacific Microbiome Therapies Market Size by Region

8.3.1 Asia-Pacific Microbiome Therapies Revenue by Region (2016-2026)

8.3.2 China Microbiome Therapies Market Size and Forecast (2016-2026)

8.3.3 Japan Microbiome Therapies Market Size and Forecast (2016-2026)

8.3.4 South Korea Microbiome Therapies Market Size and Forecast (2016-2026)

8.3.5 India Microbiome Therapies Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Microbiome Therapies Market Size and Forecast (2016-2026)

8.3.7 Australia Microbiome Therapies Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Microbiome Therapies Revenue by Type (2016-2026)

9.2 South America Microbiome Therapies Revenue by Application (2016-2026)

9.3 South America Microbiome Therapies Market Size by Country

9.3.1 South America Microbiome Therapies Revenue by Country (2016-2026)

9.3.2 Brazil Microbiome Therapies Market Size and Forecast (2016-2026)

9.3.3 Argentina Microbiome Therapies Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Microbiome Therapies Revenue by Type (2016-2026)

10.2 Middle East & Africa Microbiome Therapies Revenue by Application (2016-2026)

10.3 Middle East & Africa Microbiome Therapies Market Size by Country

10.3.1 Middle East & Africa Microbiome Therapies Revenue by Country (2016-2026)

10.3.2 Turkey Microbiome Therapies Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Microbiome Therapies Market Size and Forecast (2016-2026)

10.3.4 UAE Microbiome Therapies Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Microbiome Therapies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Microbiome Therapies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Microbiome Therapies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Microbiome Therapies Revenue (USD Million) by Region (2016-2021)

Table 5. Global Microbiome Therapies Revenue Market Share by Region (2021-2026)

Table 6. uBiome Corporate Information, Head Office, and Major Competitors

Table 7. uBiome Major Business

Table 8. uBiome Microbiome Therapies Product and Solutions

Table 9. uBiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Evolve BioSystems Corporate Information, Head Office, and Major Competitors

Table 11. Evolve BioSystems Major Business

Table 12. Evolve BioSystems Microbiome Therapies Product and Solutions

Table 13. Evolve BioSystems Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Indigo Agriculture Corporate Information, Head Office, and Major Competitors

Table 15. Indigo Agriculture Major Business

Table 16. Indigo Agriculture Microbiome Therapies Product and Solutions

Table 17. Indigo Agriculture Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Pivot Bio Corporate Information, Head Office, and Major Competitors

Table 19. Pivot Bio Major Business

Table 20. Pivot Bio Microbiome Therapies Product and Solutions

Table 21. Pivot Bio Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Concentric Ag Corporate Information, Head Office, and Major Competitors

Table 23. Concentric Ag Major Business

Table 24. Concentric Ag Microbiome Therapies Product and Solutions

Table 25. Concentric Ag Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Epibiome Corporate Information, Head Office, and Major Competitors

Table 27. Epibiome Major Business

Table 28. Epibiome Microbiome Therapies Product and Solutions

Table 29. Epibiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. CosmosID Corporate Information, Head Office, and Major Competitors

Table 31. CosmosID Major Business

Table 32. CosmosID Microbiome Therapies Product and Solutions

Table 33. CosmosID Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Human Longevity Corporate Information, Head Office, and Major Competitors

Table 35. Human Longevity Major Business

Table 36. Human Longevity Microbiome Therapies Product and Solutions

Table 37. Human Longevity Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Ajinomoto Cambrooke Corporate Information, Head Office, and Major Competitors

Table 39. Ajinomoto Cambrooke Major Business

Table 40. Ajinomoto Cambrooke Microbiome Therapies Product and Solutions

Table 41. Ajinomoto Cambrooke Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. AnimalBiome Corporate Information, Head Office, and Major Competitors

Table 43. AnimalBiome Major Business

Table 44. AnimalBiome Microbiome Therapies Product and Solutions

Table 45. AnimalBiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Microbiome Therapies Revenue (USD Million) by Players (2019-2021)

Table 47. Global Microbiome Therapies Revenue Share by Players (2019-2021)

Table 48. Breakdown of Microbiome Therapies by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Microbiome Therapies Players Head Office, Products and Services Provided

Table 50. Microbiome Therapies Mergers & Acquisitions in the Past Five Years

Table 51. Microbiome Therapies New Entrants and Expansion Plans

Table 52. Global Microbiome Therapies Revenue (USD Million) by Type (2016-2021)

Table 53. Global Microbiome Therapies Revenue Share by Type (2016-2021)

Table 54. Global Microbiome Therapies Revenue Forecast by Type (2021-2026)

Table 55. Global Microbiome Therapies Revenue by Application (2016-2021)

Table 56. Global Microbiome Therapies Revenue Forecast by Application (2021-2026)

Table 57. North America Microbiome Therapies Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Microbiome Therapies Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Microbiome Therapies Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Microbiome Therapies Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Microbiome Therapies Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Microbiome Therapies Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Microbiome Therapies Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Microbiome Therapies Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Microbiome Therapies Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Microbiome Therapies Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Microbiome Therapies Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Microbiome Therapies Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Microbiome Therapies Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Microbiome Therapies Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Microbiome Therapies Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Microbiome Therapies Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Microbiome Therapies Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Microbiome Therapies Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Microbiome Therapies Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Microbiome Therapies Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Microbiome Therapies Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Microbiome Therapies Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Microbiome Therapies Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Microbiome Therapies Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Microbiome Therapies Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Microbiome Therapies Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Microbiome Therapies Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Microbiome Therapies Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Microbiome Therapies Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Microbiome Therapies Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Microbiome Therapies Picture

Figure 2. Global Microbiome Therapies Revenue Market Share by Microbes in 2020

Figure 3. Bacteria

Figure 4. Fungi

Figure 5. Virus

Figure 6. Others

Figure 7. Microbiome Therapies Revenue Market Share by End User in 2020

Figure 8. Testing Centres Picture

Figure 9. Research Labs Picture

Figure 10. Horticulture Picture

Figure 11. Others Picture

Figure 12. Global Microbiome Therapies Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Microbiome Therapies Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Microbiome Therapies Revenue Market Share by Region (2016-2026)

Figure 15. Global Microbiome Therapies Revenue Market Share by Region in 2020

Figure 16. North America Microbiome Therapies Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Microbiome Therapies Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Microbiome Therapies Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Microbiome Therapies Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Microbiome Therapies Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Microbiome Therapies Market Drivers

Figure 22. Microbiome Therapies Market Restraints

Figure 23. Microbiome Therapies Market Trends

Figure 24. uBiome Recent Developments and Future Plans

Figure 25. Evolve BioSystems Recent Developments and Future Plans

Figure 26. Indigo Agriculture Recent Developments and Future Plans

Figure 27. Pivot Bio Recent Developments and Future Plans

Figure 28. Concentric Ag Recent Developments and Future Plans

Figure 29. Epibiome Recent Developments and Future Plans

Figure 30. CosmosID Recent Developments and Future Plans

Figure 31. Human Longevity Recent Developments and Future Plans

Figure 32. Ajinomoto Cambrooke Recent Developments and Future Plans

Figure 33. AnimalBiome Recent Developments and Future Plans

Figure 34. Global Microbiome Therapies Revenue Share by Players in 2020

Figure 35. Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 36. Global Top 3 Players Microbiome Therapies Revenue Market Share in 2020

Figure 37. Global Top 10 Players Microbiome Therapies Revenue Market Share in 2020

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 39. Global Microbiome Therapies Revenue Share by Type in 2020

Figure 40. Global Microbiome Therapies Market Share Forecast by Type (2021-2026)

Figure 41. Global Microbiome Therapies Revenue Share by Application in 2020

Figure 42. Global Microbiome Therapies Market Share Forecast by Application (2021-2026)

Figure 43. North America Microbiome Therapies Sales Market Share by Type (2016-2026)

Figure 44. North America Microbiome Therapies Sales Market Share by Application (2016-2026)

Figure 45. North America Microbiome Therapies Revenue Market Share by Country (2016-2026)

Figure 46. United States Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Microbiome Therapies Sales Market Share by Type (2016-2026)

Figure 50. Europe Microbiome Therapies Sales Market Share by Application (2016-2026)

Figure 51. Europe Microbiome Therapies Revenue Market Share by Country (2016-2026)

Figure 52. Germany Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. France Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. United Kingdom Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Russia Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Italy Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Asia-Pacific Microbiome Therapies Sales Market Share by Type (2016-2026)

Figure 58. Asia-Pacific Microbiome Therapies Sales Market Share by Application (2016-2026)

Figure 59. Asia-Pacific Microbiome Therapies Revenue Market Share by Region (2016-2026)

Figure 60. China Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Japan Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South Korea Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. India Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Southeast Asia Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Australia Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South America Microbiome Therapies Sales Market Share by Type (2016-2026)

Figure 67. South America Microbiome Therapies Sales Market Share by Application (2016-2026)

Figure 68. South America Microbiome Therapies Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East and Africa Microbiome Therapies Sales Market Share by Type (2016-2026)

Figure 72. Middle East and Africa Microbiome Therapies Sales Market Share by Application (2016-2026)

Figure 73. Middle East and Africa Microbiome Therapies Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. UAE Microbiome Therapies Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source